Pharmaceutical Chemistry Journal

, Volume 23, Issue 7, pp 541–543 | Cite as

Influence of thymotropin on processes of spontaneous and induced mutation in mammalian marrow cells

  • G. N. Zolotareva
  • N. S. Loginova
Molecular Biological Problems in the Creation of Drugs and the Study of the Mechanism of their Action


Organic Chemistry Marrow Cell Induce Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    V. N. Anisimov, V. T. Morozov, and V. Kh. Khavinson, Dokl. Akad. Nauk SSSR,263, No. 3, 742 (1982).Google Scholar
  2. 2.
    F. M. Burnet, Cellular Immunology [Russian translation], Moscow (1971).Google Scholar
  3. 3.
    Z. V. Ermol'eva, Antibiotics, Bacterial Polysaccharides, and Interferon [in Russian], Moscow (1968).Google Scholar
  4. 4.
    G. N. Zolotareva, É. A. Akaeva, É. M. Iskhakova, et al., Khim.-farm. Zh., No. 3, 19–22 (1978).Google Scholar
  5. 5.
    G. N. Zolotareva, É. A. Rudzit, G. N. Neshchadim, et al., ibid., No. 4, 392–394 (1983).Google Scholar
  6. 6.
    V. T. Morozov and V. Kh. Khavinson, Usp. Sovrem. Biol.,97, No. 1, 36–49 (1984).Google Scholar
  7. 7.
    N. N. Nosik, O. V. Parshina, N. S. Khromov, and F. I. Ershov, Vopr. Virusol., No. 1, 64–67 (1985).Google Scholar
  8. 8.
    N. N. Nosik, O. V. Parshina, G. T. Sukhikh, et al., ibid., No. 6, 729–732.Google Scholar
  9. 9.
    Yu. A. Revazova and L. U. Radchenko, Genetika,12, No. 2, 165–167 (1976).Google Scholar
  10. 10.
    T. A. Sinel'shchikova and G. D. Zasukhina, Dokl. Akad. Nauk SSSR,258, No. 5, 1231–1232 (1981).Google Scholar
  11. 11.
    L. M. Fonshtein, G. N. Zolotareva, Yu. A. Revazova, et al., Khim.-farm. Zh., No. 2, 24–29 (1978).Google Scholar
  12. 12.
    V. M. Chesnokova, L. I. Ivanova, and E. V. Gruntenko, Usp. Sovrem. Biol.,97, No. 3, 435–445 (1984).Google Scholar
  13. 13.
    L. N. Chetverikova, L. N. Garmashova, and R. Ya. Polyak, Vopr. Virusol., No. 12, 150–152 (1980).Google Scholar
  14. 14.
    T. N. Shvetsova, G. D. Zasukhina, T. A. Bektemirov, et al., Genetika,17, No. 7, 1294–1298 (1981).Google Scholar
  15. 15.
    A. L. Goldstein, S. Bäneryee, G. L. Schneebele, et al., Radiat. Res.,41, 579 (1970).Google Scholar
  16. 16.
    A. L. Goldstein, T. L. Low, A. Thurman, et al., Recent Prog. Hormone Res.,37, 369 (1981).Google Scholar
  17. 17.
    S. M. Milcu, J. Potop, V. Boeru, and N. Olinici, Ann. N.Y. Acad. Sci.,249, 380 (1975).Google Scholar
  18. 18.
    P. H. Naylor, G. Thurmun, and A. L. Goldstein, Immun. Immunopathol.,15, 867 (1979).Google Scholar
  19. 19.
    C. I. Parhon, I. Potop. E. Juvina, et al., Stud. Cercet. Endocr.,9, 161 (1958).Google Scholar
  20. 20.
    N. Trainin and M. Linker-Israeli, Cancer Res.,27, 309 (1967).Google Scholar

Copyright information

© Plenum Publishing Corporation 1990

Authors and Affiliations

  • G. N. Zolotareva
    • 1
  • N. S. Loginova
    • 1
  1. 1.Scientific Research Institute of Drug Technology and Safety

Personalised recommendations